Comment on whether the FDA is doing enough to protect the public

The PopTort is reporting on a number of studies that support the conclusion that the FDA isn’t protecting the public from safety problems that arise once a drug is on the market.  This really should not be surprising to anyone, though, given how under-resourced the FDA is, how lax our regulatory laws are, and how conflicts of interest routinely interfere with this agency’s safety role. Go here to read the comment, which cites and links to studies by the Institute of Medicine, the Journal of the American Medical Association and an article in the New York Times.